A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2006; you can also visit the original URL.
The file type is
IBM Systems Journal
Despite year-to-year increases in R & D budgets, the number of successful NCEs (new chemical entities) has continued to decline. Drug companies are looking into new ways to make research processes more efficient, to manage information better, and to improve collaboration among research groups. This shift from an artisan approach to an organized, streamlined discovery process is often termed the "industrialization of discovery processes." This paper presents an approach to industrializing drugdoi:10.1147/sj.441.0145 fatcat:zsphegfo4bcijc7qra4vsnmxua